))
Good Manufacturing Practices (GMP) in Phage Therapy with Dr. Frenk Smrekar, founder and CEO at JAFRAL
Manage episode 365942103 series 3287704
Контент предоставлен Steven Yang. Весь контент подкастов, включая эпизоды, графику и описания подкастов, загружается и предоставляется непосредственно компанией Steven Yang или ее партнером по платформе подкастов. Если вы считаете, что кто-то использует вашу работу, защищенную авторским правом, без вашего разрешения, вы можете выполнить процедуру, описанную здесь https://ru.player.fm/legal.
Standardizing the phage therapy industry through processes like clinical trails is the way to go . One of the fundamental steps to broader use of phage therapy and successful therapy is producing phages following Good Manufacturing Practices (GMP) and JAFRAL is the leader in this field. In today's show we sit down with JAFRAL's founder and CEO Dr. Frenk Smrekar, a visionary who has been working on the development of GMP for bacteriophages throughout his whole career. Let's give a listen to his journey of founding the company and his observation and thought on the phage therapy field development through a GMP perspective.
Learning more about JAFRAL @https://jafral.com
A review paper on GMP in Phage Therapy by https://doi.org/10.3389/fmicb.2020.01161
19 эпизодов
Поделиться
